semaglutide and neuropathy Wegovy may raise risk of ischemic optic 👁️ The obesity drug semaglutide, marketed as Wegovy, was associated with a significantly higher risk of ischemic optic neuropathy than the diabetes formulation Ozempic Ozempic & Neuropathy: Clinical Evidence

It includes the extra month on your treatment plan, the emotional cost of frustration and doubt, and the potential for you to give up on a medication that was actually working, just not at full strength

Although more research is needed, these findings suggest that metabolic therapies may influence the progression of musculoskeletal disease

Facile synthesis of a biocompatible silver nanoparticle derived tripeptide supramolecular hydrogel for antibacterial wound dressings

Diallo A, Carlos-Bolumbu M, Galtier F

For those struggling to determine the ideal solution for their condition, obtaining expert medical advice would be an excellent initial approach

This preserves lean mass during weight loss, which is especially important for desk workers who already have lower muscle mass from inactivity